Optimization Research of Clinical treatment Scheme of traditional Chinese Medicine for multiple Sclerosis
- Conditions
- Multiple sclerosis
- Registration Number
- ITMCTR2100004480
- Lead Sponsor
- Beijing Tiantan Hospital Affiliated to Capital Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Subjects aged 18-60 years old;
2. Subjects who met the modified McDonald's criteria for MS diagnosis in 2017;
3. Patients with acute disease;
4. Patients with written informed consent.
1. The patients who are allergic or contraindicated to the drugs such as hormone and some components of traditional Chinese medicine in the treatment plan;
2. Patients with HIV infection or active hepatitis A or syphilis infection; with history or signs of immunodeficiency;
3. Epileptic patients who failed to fully control after treatment;
4. Patients with serious systemic diseases such as heart, lung, liver, kidney and blood system;
5. Patients with history of severe depression or suicide attempt or suicidal tendency at present;
6. Patients during pregnancy or lactation;
7. Patients with serious adverse reactions during the treatment, making the treatment unable to continue;
8. Patients who use drugs that may affect the test results;
9. Patients who fail to complete all treatment plans or quit halfway as required;
10. Any other circumstances that the researcher considers unsuitable for the trial.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total marked effective rate;
- Secondary Outcome Measures
Name Time Method annualized relapse rate;Multiple Sclerosis Impact Scale;expanded disability status scale;